Log In
BCIQ
Print this Print this
 

HP-3060

  Manage Alerts
Collapse Summary General Information
Company Hisamitsu Pharmaceutical Co. Inc.
DescriptionSystemic patch formulation of an undisclosed ingredient that uses Hisamitsu's transdermal drug delivery system
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase II
Standard IndicationRhinitis
Indication DetailsTreat allergic rhinitis
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today